Global Latent Tuberculosis Infection (LTBI) Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • receipt Report ID : 99409
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Latent Tuberculosis Infection (LTBI) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Latent Tuberculosis Infection (LTBI) Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 1593.2 million by 2025, from USD 1301 million in 2019.

Market segmentation

Latent Tuberculosis Infection (LTBI) Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Latent Tuberculosis Infection (LTBI) Testing market has been segmented into:

Tuberculin Skin Test (TST)

Interferon Gamma Released Assay (IGRA)

By Application, Latent Tuberculosis Infection (LTBI) Testing has been segmented into:

Hospitals and Clinics

Diagnostic Laboratories

Others

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Latent Tuberculosis Infection (LTBI) Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Latent Tuberculosis Infection (LTBI) Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Latent Tuberculosis Infection (LTBI) Testing market.

The report offers in-depth assessment of the growth and other aspects of the Latent Tuberculosis Infection (LTBI) Testing market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Latent Tuberculosis Infection (LTBI) Testing Market Share Analysis

Latent Tuberculosis Infection (LTBI) Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Latent Tuberculosis Infection (LTBI) Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Latent Tuberculosis Infection (LTBI) Testing sales, revenue and market share for each player covered in this report.

The major players covered in Latent Tuberculosis Infection (LTBI) Testing are:

Qiagen

Thermo Fisher Scientific

Sanofi

Oxford Immunotec

Bio-Rad Laboratories

Par Sterile

Among other players domestic and global, Latent Tuberculosis Infection (LTBI) Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Latent Tuberculosis Infection (LTBI) Testing Market Overview

1.1 Product Overview and Scope of Latent Tuberculosis Infection (LTBI) Testing

1.2 Classification of Latent Tuberculosis Infection (LTBI) Testing by Type

1.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type in 2019

1.2.3 Tuberculin Skin Test (TST)

1.2.4 Interferon Gamma Released Assay (IGRA)

1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market by Application

1.3.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Hospitals and Clinics

1.3.3 Diagnostic Laboratories

1.3.4 Others

1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market by Regions

1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Latent Tuberculosis Infection (LTBI) Testing (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)

2 Company Profiles

2.1 Qiagen

2.1.1 Qiagen Details

2.1.2 Qiagen Major Business

2.1.3 Qiagen SWOT Analysis

2.1.4 Qiagen Product and Services

2.1.5 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

2.2 Thermo Fisher Scientific

2.2.1 Thermo Fisher Scientific Details

2.2.2 Thermo Fisher Scientific Major Business

2.2.3 Thermo Fisher Scientific SWOT Analysis

2.2.4 Thermo Fisher Scientific Product and Services

2.2.5 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

2.3 Sanofi

2.3.1 Sanofi Details

2.3.2 Sanofi Major Business

2.3.3 Sanofi SWOT Analysis

2.3.4 Sanofi Product and Services

2.3.5 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

2.4 Oxford Immunotec

2.4.1 Oxford Immunotec Details

2.4.2 Oxford Immunotec Major Business

2.4.3 Oxford Immunotec SWOT Analysis

2.4.4 Oxford Immunotec Product and Services

2.4.5 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

2.5 Bio-Rad Laboratories

2.5.1 Bio-Rad Laboratories Details

2.5.2 Bio-Rad Laboratories Major Business

2.5.3 Bio-Rad Laboratories SWOT Analysis

2.5.4 Bio-Rad Laboratories Product and Services

2.5.5 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

2.6 Par Sterile

2.6.1 Par Sterile Details

2.6.2 Par Sterile Major Business

2.6.3 Par Sterile Product and Services

2.6.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Latent Tuberculosis Infection (LTBI) Testing Players Market Share

3.2.2 Top 10 Latent Tuberculosis Infection (LTBI) Testing Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Market Share by Regions

4.2 North America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

4.3 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

4.5 South America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

5 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries

5.1 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)

5.2 USA Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

5.3 Canada Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

5.4 Mexico Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

6 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries

6.1 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)

6.2 Germany Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

6.3 UK Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

6.4 France Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

6.5 Russia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

6.6 Italy Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries

7.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)

7.2 China Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

7.3 Japan Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

7.4 Korea Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

7.5 India Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

8 South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries

8.1 South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)

8.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

8.3 Argentina Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Latent Tuberculosis Infection (LTBI) Testing by Countries

9.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)

9.2 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

9.3 UAE Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

9.4 Egypt Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

9.5 South Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Market Share by Type (2015-2020)

10.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2019-2024)

10.3 Tuberculin Skin Test (TST) Revenue Growth Rate (2015-2025)

10.4 Interferon Gamma Released Assay (IGRA) Revenue Growth Rate (2015-2025)

11 Global Latent Tuberculosis Infection (LTBI) Testing Market Segment by Application

11.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2015-2020)

11.2 Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2019-2024)

11.3 Hospitals and Clinics Revenue Growth (2015-2020)

11.4 Diagnostic Laboratories Revenue Growth (2015-2020)

11.5 Others Revenue Growth (2015-2020)

12 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2021-2025)

12.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2021-2025)

12.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Regions (2021-2025)

12.3 North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)

12.4 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)

12.6 South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Latent Tuberculosis Infection (LTBI) Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Qiagen Corporate Information, Location and Competitors

Table 7. Qiagen Latent Tuberculosis Infection (LTBI) Testing Major Business

Table 8. Qiagen Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)

Table 9. Qiagen SWOT Analysis

Table 10. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 11. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 12. Thermo Fisher Scientific Corporate Information, Location and Competitors

Table 13. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Major Business

Table 14. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2018-2019)

Table 15. Thermo Fisher Scientific SWOT Analysis

Table 16. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 17. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 18. Sanofi Corporate Information, Location and Competitors

Table 19. Sanofi Latent Tuberculosis Infection (LTBI) Testing Major Business

Table 20. Sanofi Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)

Table 21. Sanofi SWOT Analysis

Table 22. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 23. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 24. Oxford Immunotec Corporate Information, Location and Competitors

Table 25. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Major Business

Table 26. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)

Table 27. Oxford Immunotec SWOT Analysis

Table 28. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 29. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 30. Bio-Rad Laboratories Corporate Information, Location and Competitors

Table 31. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Major Business

Table 32. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)

Table 33. Bio-Rad Laboratories SWOT Analysis

Table 34. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 35. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 36. Par Sterile Corporate Information, Location and Competitors

Table 37. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Major Business

Table 38. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)

Table 39. Par Sterile SWOT Analysis

Table 40. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 41. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 42. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Players (2015-2020)

Table 43. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players (2015-2020)

Table 44. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Regions (2015-2020)

Table 45. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions (2015-2020)

Table 46. North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)

Table 47. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Table 48. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Countries (2015-2020)

Table 49. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Countries (2015-2020)

Table 50. South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)

Table 51. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Table 52. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Countries (2015-2020)

Table 53. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Table 54. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Type (2015-2020)

Table 55. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2015-2020)

Table 56. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Type (2021-2025)

Table 57. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2015-2020)

Table 58. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application (2015-2020)

Table 59. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Application (2021-2025)

Table 60. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Latent Tuberculosis Infection (LTBI) Testing Picture

Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type in 2019

Figure 3. Tuberculin Skin Test (TST) Picture

Figure 4. Interferon Gamma Released Assay (IGRA) Picture

Figure 5. Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application in 2019

Figure 6. Hospitals and Clinics Picture

Figure 7. Diagnostic Laboratories Picture

Figure 8. Others Picture

Figure 9. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2015-2025)

Figure 10. North America Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 11. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 12. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 13. South America Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 14. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players in 2019

Figure 17. Global Top 5 Players Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share in 2019

Figure 18. Global Top 10 Players Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share in 2019

Figure 19. Key Players Market Share Trend

Figure 20. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 21. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions (2015-2020)

Figure 22. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions in 2018

Figure 23. North America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 24. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 25. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 26. South America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 27. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 28. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Figure 29. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2019

Figure 30. USA Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 31. Canada Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 32. Mexico Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 33. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Figure 34. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2019

Figure 35. Germany Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 36. UK Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 37. France Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 38. Russia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 39. Italy Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 40. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Figure 41. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2019

Figure 42. China Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 43. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 44. Korea Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 45. India Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 46. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 47. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Figure 48. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2019

Figure 49. Brazil Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 50. Argentina Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 51. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Figure 52. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2019

Figure 53. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 54. UAE Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 55. Egypt Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 56. South Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)

Figure 57. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2015-2020)

Figure 58. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type in 2019

Figure 59. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2021-2025)

Figure 60. Global Tuberculin Skin Test (TST) Revenue Growth Rate (2015-2020)

Figure 61. Global Interferon Gamma Released Assay (IGRA) Revenue Growth Rate (2015-2020)

Figure 62. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application (2015-2020)

Figure 63. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application in 2019

Figure 64. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2021-2025)

Figure 65. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)

Figure 66. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)

Figure 67. Global Others Revenue Growth Rate (2015-2020)

Figure 68. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 69. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 70. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share Forecast by Regions (2021-2025)

Figure 71. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)

Figure 72. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)

Figure 73. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)

Figure 74. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)

Figure 75. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz